Annual Operating Expenses
$519.10 M
-$27.20 M-4.98%
31 December 2023
Summary:
Emergent BioSolutions annual total operating expenses is currently $519.10 million, with the most recent change of -$27.20 million (-4.98%) on 31 December 2023. During the last 3 years, it has risen by +$32.40 million (+6.66%). EBS annual operating expenses is now -4.98% below its all-time high of $546.30 million, reached on 31 December 2022.EBS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$96.70 M
-$31.60 M-24.63%
30 September 2024
Summary:
Emergent BioSolutions quarterly total operating expenses is currently $96.70 million, with the most recent change of -$31.60 million (-24.63%) on 30 September 2024. Over the past year, it has dropped by -$14.40 million (-12.96%). EBS quarterly operating expenses is now -36.59% below its all-time high of $152.50 million, reached on 31 March 2023.EBS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.0% | -13.0% |
| 3 y3 years | +6.7% | -25.2% |
| 5 y5 years | +77.0% | -0.8% |
EBS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.0% | +6.7% | -36.6% | at low |
| 5 y | 5 years | -5.0% | +77.0% | -36.6% | at low |
| alltime | all time | -5.0% | >+9999.0% | -36.6% | +514.2% |
Emergent BioSolutions Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $96.70 M(-24.6%) |
| June 2024 | - | $128.30 M(+18.8%) |
| Mar 2024 | - | $108.00 M(-16.0%) |
| Dec 2023 | $519.10 M(-5.0%) | $128.60 M(+15.8%) |
| Sept 2023 | - | $111.10 M(-12.5%) |
| June 2023 | - | $126.90 M(-16.8%) |
| Mar 2023 | - | $152.50 M(+0.9%) |
| Dec 2022 | $546.30 M(+7.5%) | $151.20 M(+25.4%) |
| Sept 2022 | - | $120.60 M(-12.4%) |
| June 2022 | - | $137.60 M(+1.5%) |
| Mar 2022 | - | $135.60 M(+11.1%) |
| Dec 2021 | $508.20 M(+4.4%) | $122.10 M(-5.6%) |
| Sept 2021 | - | $129.30 M(-0.4%) |
| June 2021 | - | $129.80 M(+2.2%) |
| Mar 2021 | - | $127.00 M(+7.8%) |
| Dec 2020 | $486.70 M(+11.7%) | $117.80 M(-20.9%) |
| Sept 2020 | - | $149.00 M(+29.2%) |
| June 2020 | - | $115.30 M(+10.2%) |
| Mar 2020 | - | $104.60 M(-16.8%) |
| Dec 2019 | $435.90 M(+48.6%) | $125.70 M(+28.9%) |
| Sept 2019 | - | $97.50 M(-10.1%) |
| June 2019 | - | $108.40 M(+3.9%) |
| Mar 2019 | - | $104.30 M(-12.8%) |
| Dec 2018 | $293.30 M(+64.4%) | $119.60 M(+84.6%) |
| Sept 2018 | - | $64.80 M(+25.6%) |
| June 2018 | - | $51.60 M(-9.6%) |
| Mar 2018 | - | $57.10 M(-8.6%) |
| Dec 2017 | $178.40 M(+57.0%) | $62.48 M(+52.6%) |
| Sept 2017 | - | $40.94 M(+11.8%) |
| June 2017 | - | $36.62 M(-4.6%) |
| Mar 2017 | - | $38.37 M(+92.0%) |
| Dec 2016 | $113.60 M(-7.6%) | $19.98 M(-45.1%) |
| Sept 2016 | - | $36.37 M(+17.1%) |
| June 2016 | - | $31.07 M(+18.7%) |
| Mar 2016 | - | $26.18 M(-26.0%) |
| Dec 2015 | $122.94 M | $35.38 M(+16.2%) |
| Sept 2015 | - | $30.45 M(-27.8%) |
| June 2015 | - | $42.16 M(+5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $40.10 M(+3350.6%) |
| Dec 2014 | $121.64 M(-20.5%) | $1.16 M(-96.2%) |
| Sept 2014 | - | $30.43 M(-32.5%) |
| June 2014 | - | $45.09 M(+0.3%) |
| Mar 2014 | - | $44.95 M(+4.7%) |
| Dec 2013 | $152.99 M(+17.5%) | $42.96 M(+12.8%) |
| Sept 2013 | - | $38.09 M(+12.2%) |
| June 2013 | - | $33.94 M(-10.7%) |
| Mar 2013 | - | $38.01 M(+8.1%) |
| Dec 2012 | $130.24 M(+1.6%) | $35.16 M(+3.5%) |
| Sept 2012 | - | $33.96 M(+8.4%) |
| June 2012 | - | $31.32 M(+5.2%) |
| Mar 2012 | - | $29.78 M(-227.6%) |
| Dec 2011 | $128.14 M(-2.0%) | -$23.34 M(-150.0%) |
| Sept 2011 | - | $46.65 M(-10.1%) |
| June 2011 | - | $51.87 M(-2.1%) |
| Mar 2011 | - | $52.97 M(+221.1%) |
| Dec 2010 | $130.71 M(-11.9%) | $16.50 M(-60.6%) |
| Sept 2010 | - | $41.85 M(+15.4%) |
| June 2010 | - | $36.25 M(+0.4%) |
| Mar 2010 | - | $36.11 M(-4.7%) |
| Dec 2009 | $148.37 M(+29.5%) | $37.90 M(-1.7%) |
| Sept 2009 | - | $38.54 M(-3.8%) |
| June 2009 | - | $40.05 M(+25.6%) |
| Mar 2009 | - | $31.89 M(+13.8%) |
| Dec 2008 | $114.55 M(+4.6%) | $28.03 M(-8.8%) |
| Sept 2008 | - | $30.74 M(-4.7%) |
| June 2008 | - | $32.24 M(+37.0%) |
| Mar 2008 | - | $23.54 M(-18.7%) |
| Dec 2007 | $109.51 M(+21.5%) | $28.93 M(+4.0%) |
| Sept 2007 | - | $27.82 M(+7.0%) |
| June 2007 | - | $26.00 M(-2.8%) |
| Mar 2007 | - | $26.76 M(-12.3%) |
| Dec 2006 | $90.10 M(+76.1%) | $30.51 M(+23.5%) |
| Sept 2006 | - | $24.70 M |
| Dec 2005 | $51.17 M(+26.5%) | - |
| Dec 2004 | $40.44 M(+149.6%) | - |
| Dec 2002 | $16.20 M(<-9900.0%) | - |
| Dec 2001 | -$119.00 K | - |
FAQ
- What is Emergent BioSolutions annual total operating expenses?
- What is the all time high annual operating expenses for Emergent BioSolutions?
- What is Emergent BioSolutions annual operating expenses year-on-year change?
- What is Emergent BioSolutions quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly operating expenses year-on-year change?
What is Emergent BioSolutions annual total operating expenses?
The current annual operating expenses of EBS is $519.10 M
What is the all time high annual operating expenses for Emergent BioSolutions?
Emergent BioSolutions all-time high annual total operating expenses is $546.30 M
What is Emergent BioSolutions annual operating expenses year-on-year change?
Over the past year, EBS annual total operating expenses has changed by -$27.20 M (-4.98%)
What is Emergent BioSolutions quarterly total operating expenses?
The current quarterly operating expenses of EBS is $96.70 M
What is the all time high quarterly operating expenses for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly total operating expenses is $152.50 M
What is Emergent BioSolutions quarterly operating expenses year-on-year change?
Over the past year, EBS quarterly total operating expenses has changed by -$14.40 M (-12.96%)